NDC 86136-141 - Enrosite
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86136-141
- Package NDCs from labels
- 86136-141-31
- Manufacturer
- MWI/Vetone | FELIX PHARMACEUTICALS PRIVATE LIMITED
- Effective date
- 2026-03-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enrosite - MWI/Vetone | FELIX PHARMACEUTICALS PRIVATE LIMITED | MWI/Vetone | FELIX PHARMACEUTICALS PRIVATE LIMITED | 2026-03-13 | Prescription Animal Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86136-141-31 | Enrosite | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 3 | |
| 86136-141-31 | Enrosite | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.